Chertow GM - Search Results

1

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.

Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Åstrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM. Block GA, et al. Among authors: chertow gm. J Am Soc Nephrol. 2017 Jun;28(6):1933-1942. doi: 10.1681/ASN.2016080855. Epub 2017 Feb 3. J Am Soc Nephrol. 2017. PMID: 28159782 Free PMC article. Clinical Trial.

2

"Wishing don't make it so"--why we need a randomized clinical trial of high-intensity hemodialysis.

Chertow GM. Chertow GM. J Am Soc Nephrol. 2001 Dec;12(12):2850-2853. doi: 10.1681/ASN.V12122850. J Am Soc Nephrol. 2001. PMID: 11729257 Review. No abstract available.

3

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.

Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD. Chertow GM, et al. Am J Nephrol. 2003 Sep-Oct;23(5):307-14. doi: 10.1159/000072822. Epub 2003 Aug 12. Am J Nephrol. 2003. PMID: 12915774 Clinical Trial.

4

Slowing the progression of vascular calcification in hemodialysis.

Chertow GM. Chertow GM. J Am Soc Nephrol. 2003 Sep;14(9 Suppl 4):S310-4. doi: 10.1097/01.asn.0000081666.10967.05. J Am Soc Nephrol. 2003. PMID: 12939387 Review.

5

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Block GA, et al. Among authors: chertow gm. J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/01.ASN.0000133041.27682.A2. J Am Soc Nephrol. 2004. PMID: 15284307

6

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ. Moe SM, et al. Among authors: chertow gm. Kidney Int. 2005 Feb;67(2):760-71. doi: 10.1111/j.1523-1755.2005.67139.x. Kidney Int. 2005. PMID: 15673327 Free article. Clinical Trial.

7

Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.

Garg JP, Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM, Bakris GL. Garg JP, et al. Among authors: chertow gm. Am J Nephrol. 2005 Jul-Aug;25(4):393-9. doi: 10.1159/000087211. Epub 2005 Jul 25. Am J Nephrol. 2005. PMID: 16088080 Clinical Trial.

8

Survival by dialysis modality in critically ill patients with acute kidney injury.

Cho KC, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Cho KC, et al. Among authors: chertow gm. J Am Soc Nephrol. 2006 Nov;17(11):3132-8. doi: 10.1681/ASN.2006030268. Epub 2006 Oct 4. J Am Soc Nephrol. 2006. PMID: 17021268

9

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.

Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P. Chertow GM, et al. Clin J Am Soc Nephrol. 2007 Sep;2(5):898-905. doi: 10.2215/CJN.04381206. Epub 2007 Aug 16. Clin J Am Soc Nephrol. 2007. PMID: 17702710

10

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.

Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA; TARGET Investigators. Block GA, et al. Among authors: chertow gm. Nephrol Dial Transplant. 2008 Jul;23(7):2311-8. doi: 10.1093/ndt/gfn026. Epub 2008 Feb 29. Nephrol Dial Transplant. 2008. PMID: 18310602 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

850 results

Search Page

Filters